A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure

NCT01173471 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Raised Intraocular Pressure

Interventions

DRUG: AZD4017
DRUG: Placebo
DRUG: AZD4017
DRUG: Placebo

Sponsor

AstraZeneca